Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.fdcindia.com | |
Market Cap | 4,313.66 Cr. | |
Enterprise Value(EV) | 4,311.70 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | 10.17 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | 25.67 | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.80 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 114.55 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.28 | Calculated using Price: 261.05 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 16.59 Cr. | 165,910,084 Shares |
FaceValue | 1 | |
Company Profile | ||
FDC Limited is among India's leading fully integrated pharmaceutical companies. The Company is a pioneer in the manufacture of specialised formulations, and among the world's foremost manufacturers and marketers of Oral Rehydration Salts (ORS). Over its long history of 85 years, the Company has maintained a distinguished reputation for high-quality, affordable products and built a market-leading brand portfolio. |
1 Day |
|
+0.19% |
1 Week |
|
-1.93% |
1 Month |
|
-4.31% |
3 Month |
|
-15.15% |
6 Month |
|
-4.06% |
1 Year |
|
-14.69% |
2 Year |
|
-9.50% |
5 Year |
|
+2.51% |
10 Year |
|
+182.37% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 16.63 | 16.64 | 16.72 | 16.03 | 13.63 | 12.48 | 16.03 | 18.36 | 11.71 | |
Return on Capital Employed (%) | 27.12 | 23.02 | 23.11 | 21.51 | 19.00 | 17.49 | 21.56 | 23.74 | 15.78 | |
Return on Assets (%) | 13.26 | 13.34 | 13.97 | 12.00 | 9.03 | 8.20 | 10.43 | 11.85 | 7.59 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 845 | 936 | 1,082 | 1,270 | 1,276 | 1,445 | 1,547 | 1,734 | 1,957 | 1,901 | |
Non Curr. Liab. | 31 | 24 | 20 | 217 | 211 | 229 | 315 | 300 | 391 | 33 | |
Curr. Liab. | 196 | 188 | 163 | 389 | 480 | 497 | 565 | 622 | 690 | 365 | |
Minority Int. | 0 | 0 | 0 | ||||||||
Equity & Liab. | 1,072 | 1,148 | 1,266 | 1,876 | 1,968 | 2,172 | 2,427 | 2,655 | 3,038 | 2,297 | |
Non Curr. Assets | 619 | 646 | 742 | 958 | 977 | 1,113 | 1,181 | 1,303 | 1,620 | 1,281 | |
Curr. Assets | 452 | 502 | 523 | 918 | 991 | 1,058 | 1,245 | 1,352 | 1,418 | 1,016 | |
Misc. Exp. not W/O | 0 | ||||||||||
Total Assets | 1,072 | 1,148 | 1,266 | 1,876 | 1,968 | 2,172 | 2,427 | 2,655 | 3,038 | 2,297 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 846 | 889 | 994 | 1,014 | 1,075 | 1,091 | 1,344 | 1,333 | 1,528 | 1,622 | |
Other Income | 42 | 46 | 39 | 50 | 51 | 43 | 69 | 97 | 76 | 54 | |
Total Income | 888 | 935 | 1,033 | 1,064 | 1,126 | 1,134 | 1,413 | 1,430 | 1,604 | 1,677 | |
Total Expenditure | -641 | -691 | -766 | -770 | -848 | -860 | -1,051 | -999 | -1,274 | -1,410 | |
PBIDT | 246 | 244 | 268 | 294 | 278 | 274 | 362 | 431 | 330 | 267 | |
Interest | -3 | -2 | -1 | -1 | -1 | -1 | -3 | -3 | -3 | -3 | |
Depreciation | -25 | -39 | -34 | -35 | -35 | -33 | -37 | -38 | -37 | -38 | |
Taxation | -83 | -56 | -63 | -63 | -67 | -67 | -80 | -87 | -73 | -57 | |
Exceptional Items | -6 | -1 | -2 | ||||||||
PAT | 135 | 148 | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 168 | |
Minority Interest | 0 | 0 | 0 | ||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 135 | 148 | 169 | 189 | 174 | 170 | 240 | 301 | 216 | 169 | |
Adjusted EPS | 8 | 8 | 9 | 11 | 10 | 10 | 14 | 18 | 13 | 10 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 150 | 150 | 128 | 174 | 154 | 150 | 112 | 250 | 207 | 162 | |
Cash Fr. Inv. | -107 | -55 | -89 | -73 | -144 | 20 | -120 | -98 | -77 | -145 | |
Cash Fr. Finan. | -63 | -75 | -48 | -97 | 0 | -169 | 0 | -142 | -129 | -10 | |
Net Change | -20 | 19 | -9 | 4 | 11 | 1 | -8 | 10 | 1 | 7 | |
Cash & Cash Eqvt | 4 | 23 | 15 | 16 | 27 | 28 | 20 | 30 | 30 | 38 |
Tue, 31 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting & Closure Of The Trading Window FDC LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2023 inter alia to consider and approve the Unaudited Financial Results along with the Limited Review Report of the Company for the quarter ended December31 2022. Further in accordance with Code of Conduct adopted by the Company SEBI (Prohibition of Insider Trading) (Amendment) Regulations 2018 and vide our Intimation letter dated December 28 2022 the Trading Window of the Company has been closed for all the Designated Persons Connected Persons and their Immediate Relatives from Sunday January 01 2023 till 48 hours after the declaration of Unaudited Financial Results for the quarter ended December 31 2022. |
Sat, 07 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Please find enclosed the certificate issued by the Registrar and Share Transfer Agent of the Company i.e. Link Intime India Pvt. Ltd. regarding the details of the securities dematerialized /rematerialized during the quarter ended on December 31 2022 as required under regulation 74 (5) of the SEBI (Depositories and Participants) Regulation 2018. |
Wed, 28 Dec 2022
Closure of Trading Window Pursuant to the SEBI (Prohibition of Insider Trading) Regulations 2015 & Amendments thereon and in compliance with Companys Code of Conduct for the Prevention of Insider Trading and Code of Fair Disclosure the Trading Window for dealing in Securities of the Company for all the Designated Persons Connected Persons and their Immediate Relative(s) shall remain closed from Sunday January 01 2023 until 48 hours after the declaration of the Unaudited Financial Results of the Company for the quarter and nine months ending on December 31 2022. The date of Board Meeting of the Company for consideration and approval of the Unaudited Financial Results for the quarter and nine months ending December 31 2022 will be intimated in due course. |
Tue, 07 Feb 2023 |
|
|
|
|
|